NewStem

NewStemNewStem
NewStem

NewStem

Biopharmaceutical company developing human haploid stem cells for regenerative medicine and disease therapy.

Website
2018ActiveRehovot, Israel
Rate
Advertise here

About

NewStem is a biopharmaceutical company specializing in Human Pluripotent Stem Cells (HPSCs), with a particular focus on Human Haploid Pluripotent Stem Cells (HHPSCs). These unique cells hold significant potential for advancing regenerative medicine and developing novel therapies for various diseases.

Technology stack

detected 2026-07-10
Emailnone
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does NewStem do?

NewStem is a biopharmaceutical company specializing in Human Pluripotent Stem Cells (HPSCs), with a particular focus on Human Haploid Pluripotent Stem Cells (HHPSCs). These unique cells hold significant potential for advancing regenerative medicine and developing novel therapies for various diseases.

How much funding has NewStem raised?

NewStem has raised a total of $30M in funding. The most recent round on record is Series B.

Where is NewStem headquartered?

NewStem is headquartered in Rehovot, Israel.

When was NewStem founded?

NewStem was founded in 2018.

What industry does NewStem operate in?

NewStem operates in Life Sciences, Biotech, Biopharmaceutical, MedTech, HealthTech, Drug Discovery.

What is NewStem's revenue?

StartupHub estimates NewStem's annual revenue at $8.5M (range $2.0M to $12.7M, 27% confidence), based on comparable companies in the sector.

What is NewStem's valuation?

StartupHub estimates NewStem's effective valuation at $117.0M (range $75.0M to $180.0M, 10% confidence), based on comparable companies in the sector.